Is Dipna Pharmachem a good stock to invest in?

Dipna Pharmachem can be analyzed on the following key metrics - TTM P/E: 11.73 Sector P/E: 22.75 Dividend Yield: 0% D/E ratio: -

Dipna Pharmachem Share Price

Sector: Chemical Manufacturing

Powered by

25.30 -0.47 (-1.82%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 25.30

Today’s High 25.31

52 Week Low 6.40

52 Week High 26.31

Key Metrics

Market Cap (In Cr) 59.68
Beta -
Div. Yield (%) 0
P/B 1.65
TTM P/E 11.73
Peg Ratio 0.14
Sector P/E 22.75
D/E 0
Open Price 25.31
Prev Close 25.77

View All Metrics

Dipna Pharmachem Analysis

Price Analysis

1 Week

8.05%
3 Months

118.39%
6 Month

281.78%
YTD

78.83%
1 Year

188.9%

Risk Meter

68% Low risk
68% Moderate risk
68% Balanced Risk
68% High risk
68% Extreme risk

Dipna Pharmachem News

The micro-cap pharma company's annual revenue surged by 37.34% in the last fiscal year, reaching a notable ₹99.93 crores.

Premium

Pharma stock to declare bonus shares, stock split this month. Details here

1 min read . 09 Apr 2024

Engineers India has declared an interim dividend of ₹2.00 per equity share.

Premium

Torrent Pharma, Cochin Shipyard, among 12 stocks to trade ex-dividend

2 min read . 12 Feb 2024

Premium

Dipna Pharmachem share price Today Live Updates : Dipna Pharmachem closed today at ₹15.95, up 0.63% from yesterday's ₹15.85

14 min read . 12 Oct 2023

Premium

Dipna Pharmachem share price Today Live Updates : Dipna Pharmachem closed today at ₹15.85, up 4.76% from yesterday's ₹15.13

12 min read . 11 Oct 2023

View More News

Dipna Pharmachem Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
164.34

Selling/ General/ Admin Expenses Total
0.44

Depreciation/ Amortization
0.02

Other Operating Expenses Total
2.55

Total Operating Expense
160.93

Operating Income
3.41

Net Income Before Taxes
1.42

Net Income
1.09

Diluted Normalized EPS
0.9

Period
2023

Total Revenue
99.93

Selling/ General/ Admin Expenses Total
0.44

Depreciation/ Amortization
0.01

Other Operating Expenses Total
1.66

Total Operating Expense
97.6

Operating Income
2.33

Net Income Before Taxes
1.38

Net Income
0.91

Diluted Normalized EPS
0.63

Period
2022

Total Revenue
72.76

Selling/ General/ Admin Expenses Total
0.61

Depreciation/ Amortization
0.01

Other Operating Expenses Total
1.34

Total Operating Expense
70.52

Operating Income
2.24

Net Income Before Taxes
1.57

Net Income
1.17

Diluted Normalized EPS
0.8

Period
2021

Total Revenue
31

Selling/ General/ Admin Expenses Total
0.41

Depreciation/ Amortization
0.01

Other Operating Expenses Total
0.61

Total Operating Expense
30.61

Operating Income
0.39

Net Income Before Taxes
0.06

Net Income
0.02

Diluted Normalized EPS
0.02

Period
2020

Total Revenue
30.54

Selling/ General/ Admin Expenses Total
0.38

Depreciation/ Amortization
0.01

Other Operating Expenses Total
0.76

Total Operating Expense
30.1

Operating Income
0.44

Net Income Before Taxes
0.06

Net Income
0.06

Diluted Normalized EPS
0.04

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Dipna Pharmachem Technical

Moving Average SMA

5 Day24.77
10 Day23.65
20 Day22.22

50 Day17.46
100 Day15.59
300 Day11.59

Dipna Pharmachem Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Eiko Lifesciences
50.79
-1.3
-2.5
74.88
42
63.08

Iel
5.2
0.09
1.76
7.1
3.36
67.01

Dipna Pharmachem
25.3
-0.47
-1.82
26.31
6.4
59.68

Shreyas Intermediates
9.88
0.88
9.78
20.2
7.79
70

Teesta Agro Industries
113
-0.05
-0.04
159.98
83.3
63.4

Dipna Pharmachem Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

12-Mar-25
Issue Of Warrants & Others

24-Feb-25
Preferential issue of shares

06-Feb-25
Preferential issue of shares

29-Jul-24
Preferential issue & Issue of Warrants

12-Jun-24
Audited Results

02-May-24
Bonus, Stock Split & Preferential issue

26-Apr-24
Bonus, Stock Split & Preferential issue

18-Oct-23
Half Yearly Results & Rights issue

11-Oct-23
Half Yearly Results & Rights issue

10-Jul-23
Audited Results

Meeting Date
Announced on
Purpose

04-Apr-25
13-Mar-25
EGM

27-Aug-24
06-Aug-24
AGM

03-Jan-24
11-Dec-23
EGM

29-Sept-23
22-Sept-23
AGM

04-Feb-23
12-Jan-23
EGM

Announced on
Record Date
Ex-Rights Date
Ratio
FV
Premium
Description

18-Oct-23
12-Feb-24
12-Feb-24
13:12
10
0
Rights issue of equity shares of Rs. 10/- in the ratio of 13:12 @ par. (RD & XD revised)

View All

Company Profile

ABOUT Dipna Pharmachem

Industry Chemical Manufacturing
ISIN INE0MC401013
BSE Code 543594

Dipna Pharmachem Limited is an India-based trader, importer, and exporter in industrial chemical and pharmaceutical raw materials, active pharmaceutical ingredients (APIs), solvents, and formulation. The Company is primarily engaged in a single segment, which is pharmaceutical trading. Its products include aceclofenac, acetazolamide, albendazole, ambroxol hcl, amisulpride ip/bp, amoxicillin aripiprazole ip, azithromycin, cefixime, carbamezapin, calcium gluconate ip, cefadroxyl monohydrate ip/bp/ep cephalexin, clindamycin phosphate ip/bp/usp, clotrimazole, cetrimide powder, chlorhexidine base, chlorhexidine hydrochloride, Bronopol, cm-1000, calcium cmc, calcium carbonate (light), calcium carbonate (oys), ceto stearyl alcohol, citric acid (anhydrous), and citric acid (monohydrate). It also provides assistance in setting up contract manufacturing compliance for regulated and semi-regulated pharmaceutical companies with all the global benchmark parameters of certificates like WHO-GMP.

DIPNA PHARMACHEM SUMMARY

Dipna Pharmachem is trading 1.82% lower at Rs 25.30 as compared to its last closing price. Dipna Pharmachem has been trading in the price range of 25.31 & 25.30. Dipna Pharmachem has given 78.83% in this year & 8.05% in the last 5 days.

Dipna Pharmachem has TTM P/E ratio 11.73 as compared to the sector P/E of 22.75.

The company posted a net profit of 0.34 Crores in its last quarter.

Listed peers of Dipna Pharmachem include Eiko Lifesciences (-2.5%), Iel (1.76%), Dipna Pharmachem (-1.82%) etc.

Dipna Pharmachem has a 9.98% promoter holding & 90.02% public holding.

FAQs about Dipna Pharmachem

Dipna Pharmachem is trading at 25.30 as on 22 May, 2025 1:15:00 PM. This is -1.82% lower as compared to its previous closing price of 25.77

The market capitalization of Dipna Pharmachem is 59.68 Cr as on 22 May, 2025 1:15:00 PM.

The 52 wk high for Dipna Pharmachem is 26.31 whereas the 52 wk low is 6.40

Dipna Pharmachem can be analyzed on the following key metrics -

TTM P/E: 11.73
Sector P/E: 22.75
Dividend Yield: 0%
D/E ratio: -

Dipna Pharmachem reported a net profit of 1.09 Cr in 2024.

Dipna Pharmachem Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Dipna Pharmachem Share Price

Price Range

Key Metrics

Dipna Pharmachem Analysis

Dipna Pharmachem News

Pharma stock to declare bonus shares, stock split this month. Details here

Torrent Pharma, Cochin Shipyard, among 12 stocks to trade ex-dividend

Dipna Pharmachem share price Today Live Updates : Dipna Pharmachem closed today at ₹15.95, up 0.63% from yesterday's ₹15.85

Dipna Pharmachem share price Today Live Updates : Dipna Pharmachem closed today at ₹15.85, up 4.76% from yesterday's ₹15.13

Dipna Pharmachem Financials

Forecast

Forecast

Forecast

Dipna Pharmachem Technical

Dipna Pharmachem Peers

Dipna Pharmachem Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Dipna Pharmachem

DIPNA PHARMACHEM SUMMARY

FAQs about Dipna Pharmachem

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue